CF

Chaim Friedman

Founding Partner at LionBird

Israel

Invests in

Stages:

Locations:

  • Min Investment:

    $1,000,000.00
  • Max Investment:

    $2,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

2012

  • Founding Partner

    2012

    LionBird provides pre-scale capital and assistance to founders defying established norms in healthcare. See www.lionbird.com

  • Mentor

    2013 - 2018

2010 - 2012

  • Senior Director, Business Development, Abbott Diagnostics

    2010 - 2012

    Chaim joined Abbott in May 2010 following the acquisition of STARLIMS Technologies. Upon joining Abbott, Chaim focused primarily on completing the integration of STARLIMS into Abbott's Diagnostic business and on putting together financial models and plans for acquisition of key STARLIMS distributors across the globe. During his tenure at Abbott, Chaim developed an effective scouting setup for new technologies and science originating from Israel’s biomed sector and academic community. Chaim’s experience in the informatics space and interest in emerging business models drove his contribution in developing Abbott's mobile health concepts

1990 - 2010

  • Co-founder, Board Member, Chief Financial Officer

    1990 - 2010

    STARLIMS develops and deploys enterprise laboratory informatics solutions . The systems manage the collection, processing, storage, retrieval and analysis of information generated in laboratories. The company’s software is used by hundreds of organizations in over 40 countries worldwide. During his 20 years at STARLIMS, Chaim directed its financial and commercial operations supporting the company’s global growth. Chaim lead the company's 2007 Nasdaq IPO and subsequent $120 million acquisition by Abbott in 2010. .